Roles of the PARP Inhibitor in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment.

Inoue, Takahiro; Sekito, Sho; Kageyama, Takumi; Sugino, Yusuke; Sasaki, Takeshi

Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment.

Inoue, Takahiro; Sekito, Sho; Kageyama, Takumi; Sugino, Yusuke; Sasaki, Takeshi.

Afiliação

Inoue T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.
Sekito S; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.
Kageyama T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.
Sugino Y; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.
Sasaki T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.

Cancers (Basel) ; 15(9)2023 May 08.

Article em En | MEDLINE | ID: mdl-37174127

Palavras-chave

BRCA1/2; DNA damage repair; PARP inhibitor; prostate cancer; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google